NSA2 pseudogene 7 (NSA2P7)

NSA2 pseudogene 7 (NSA2P7) is a non-coding pseudogene related to the NSA2 ribosome biogenesis factor gene. Pseudogenes like NSA2P7 arise through gene duplication or retrotransposition events and subsequently lose their protein-coding ability due to accumulated mutations or regulatory changes. NSA2P7 does not produce a functional protein and is not known to have any direct biological function as a therapeutic target, receptor, enzyme, transporter, or signaling molecule. While some pseudogenes act in gene regulation at the RNA level—for example, by producing regulatory transcripts or acting as competing endogenous RNAs—no such regulatory role has been documented for NSA2P7 specifically. Thus, NSA2P7 is not considered a therapeutic target, nor are there researchers or clinicians currently targeting it for drug development or as a biomarker. Key points supporting guidance: - Pseudogenes are not targets for drugs because they do not encode functional proteins. - NSA2P7 is a naming convention for one of several NSA2-related pseudogenes and does not refer to a unique, functionally annotated gene product. - If specifically seeking molecules relevant for drug targeting (e.g., receptors, transporters, enzymes), NSA2P7 should be excluded from further consideration. If more information is needed about the protein-coding gene NSA2 (NSA2 ribosome biogenesis factor), that is a different entity and does have known biological functions in ribosome assembly and cell cycle regulation. NSA2P7 itself, as a pseudogene, should not be treated as a druggable or disease-related target.

Other names

NSA2P7no widely used alternative names detected

None